Back to search

United Kingdom· GB-APID-16561011000001105

Diprosalic 0.05%/2% scalp application

A medicinal product containing salicylic acid + betamethasone, registered in United Kingdom by Mawdsley-Brooks & Company Ltd.

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedDiprosalic 0.05%/2% scalp applicationATC—REGISTER NO.GB-APID-1656101100000…PACKS LISTED0CHECKEDSeptember 13, 2026

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Salicylic acid + Betamethasone
Manufacturer
Mawdsley-Brooks & Company Ltd
Country
United Kingdom (GB)
ATC code
—
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Salicylic acid + betamethasone in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All salicylic acid + betamethasone products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

  • Austria · Betamethason/Salicylsäure Dermapharm, Diprosalic
  • Belgium · Diprosalic
  • Bulgaria · Бетадерм А, Дипросалик
  • Czechia · Belosalic, Diprosalic
  • Germany · Betadermic, Betasacyl
  • Denmark · Betamethason/Salicylsyre Orifarm, Diprosalic
  • Estonia · Diprosalic
  • Spain · Diprosalic, Syracerin
  • Finland · Diprosalic
  • France · Diprosalic
  • Croatia · Belosalic, Soderm Plus
  • Hungary · Diprosalic
  • Ireland · Diprosalic
  • Iceland · Diprosalic
  • Italy · Belasic, Diprosalic
  • Luxembourg · Diprosalic
  • Netherlands · Diprosalic
  • Norway · Diprosalic
  • Poland · Bedicort Salic, Belosalic
  • Portugal · Diprosalic, Psodermil
  • Romania · Diprosalic, Sal-Ekarzin
  • Sweden · Betametason/Salicylsyra Orifarm, Diprosalic
  • Slovenia · Belosalic, Diprosalic
  • Slovakia · Belosalic

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d38464ba-e835-4b2b-9d6e-87e5fd494540
GET /v1/drugs/d38464ba-e835-4b2b-9d6e-87e5fd494540?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "16561011000001105",
  "desc": "Diprosalic 0.05%/2% scalp application (Mawdsley-Brooks & Company Ltd)",
  "form": "Cutaneous solution",
  "vpid": "35910711000001107",
  "source": "dmd",
  "vtm_id": "774845007",
  "strength": "20 mg",
  "substance": "Salicylic acid + Betamethasone",
  "ingredient": "Salicylic acid",
  "supplier_code": "15125811000001100"
}

See everything about salicylic acid + betamethasone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.